Inogen | INGN - Debt


Inogen reported $0 in Debt for its fiscal quarter ending in June of 2022.





Debt Change Date
Abbott USD 13.86B 919M Dec/2025
Accuray USD 170.24M 4.52M Sep/2024
AngioDynamics USD 6.3M 6.3M Feb/2025
Artivion USD 317.78M 619K Dec/2024
AtriCure USD 73.38M 3.35M Dec/2025
Baxter International USD 9.78B 68M Dec/2025
Becton, Dickinson and Co. USD 19.54B 358M Dec/2025
Boston Scientific USD 11.44B 610M Dec/2025
Chart Industries USD 3.57B 84.3M Dec/2025
Cooper Companies USD 2.51B 27M Sep/2025
Dexcom USD 1.24B 900K Mar/2026
Edwards Lifesciences USD 600M 105.4M Mar/2026
Globus Medical USD 119.34M 1.76M Sep/2025
Inogen USD 0 0 Jun/2022
Insulet USD 1.01B 384.9M Sep/2025
Masimo USD 586.2M 56M Sep/2025
Medtronic USD 28.07B 1.03B Dec/2025
Orthofix International USD 137.23M 338K Sep/2024
Philips EUR 8.38B 41M Sep/2025
ResMed USD 847.72M 1.37M Dec/2025
Steris USD 2.06B 10.4M Sep/2025
Stryker USD 14.22B 635M Mar/2026
Tandem Diabetes Care USD 449.28M 276K Sep/2025
Teleflex USD 2.77B 774M Sep/2025
X T L Biopharmaceuticals USD 138K 30K Dec/2024
Zimmer Biomet Holdings USD 7.47B 48.1M Mar/2026